Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond
D Di Lisi, R Madonna, C Zito, E Bronte… - International journal of …, 2017 - Elsevier
Cardiotoxicity induced by chemotherapeutic agents and radiotherapy is a growing problem.
In recent years, an increasing number of new drugs with targeted action have been designed…
In recent years, an increasing number of new drugs with targeted action have been designed…
From molecular mechanisms to clinical management of antineoplastic drug-induced cardiovascular toxicity: a translational overview
CG Tocchetti, C Cadeddu, D Di Lisi… - Antioxidants & redox …, 2019 - liebertpub.com
Significance: Antineoplastic therapies have significantly improved the prognosis of
oncology patients. However, these treatments can bring to a higher incidence of side-effects, …
oncology patients. However, these treatments can bring to a higher incidence of side-effects, …
Chemotherapy-induced cardiotoxicity: role of the tissue Doppler in the early diagnosis of left ventricular dysfunction
D Di Lisi, F Bonura, F Macaione, A Peritore… - Anti-cancer …, 2011 - journals.lww.com
Cardiotoxicity is a common complication of chemotherapy. The aim of this study was to assess
the cardiotoxicity of anticancer drugs using tissue Doppler imaging. A prospective study …
the cardiotoxicity of anticancer drugs using tissue Doppler imaging. A prospective study …
Effectiveness and safety of oral anticoagulants in cardiac amyloidosis: lights and shadows
D Di Lisi, L Di Caccamo, G Damerino… - Current Problems in …, 2023 - Elsevier
Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy characterized by extracellular
deposition of mis-folded proteins called amyloid. Cardiac complications of CA are several: heart …
deposition of mis-folded proteins called amyloid. Cardiac complications of CA are several: heart …
Atrial strain assessment for the early detection of cancer therapy-related cardiac dysfunction in breast cancer women (the strano study: Atrial strain in cardio-oncology)
D Di Lisi, A Moreo, G Casavecchia… - Journal of Clinical …, 2023 - mdpi.com
Left ventricular global longitudinal strain (GLS) has an important role in the diagnosis of
cancer therapy-related cardiac dysfunction (CTRCD). Little is known about the role of atrial …
cancer therapy-related cardiac dysfunction (CTRCD). Little is known about the role of atrial …
Therapy of ATTR cardiac amyloidosis: current indications
D Di Lisi, V Di Stefano, F Brighina, AR Galassi… - Current Problems in …, 2023 - Elsevier
Transthyretin cardiac amyloidosis is a restrictive cardiomyopathy caused by extracellular
deposition in the heart of amyloid fibrils derived from plasma transthyretin (ATTR), either in its …
deposition in the heart of amyloid fibrils derived from plasma transthyretin (ATTR), either in its …
Chemotherapy-related cardiac dysfunction: the usefulness of myocardial work indices
D Di Lisi, G Manno, C Madaudo, C Filorizzo… - … International Journal of …, 2023 - Springer
Aims: The role of left ventricular global longitudinal strain (GLS) in the diagnosis of subclinical
cardiac damage induced by anticancer drugs is now consolidated. Considering some …
cardiac damage induced by anticancer drugs is now consolidated. Considering some …
Subclinical cardiotoxicity: the emerging role of myocardial work and other imaging techniques
D Di Lisi, G Manno, G Novo - Current Problems in Cardiology, 2021 - Elsevier
In recent years, the cancer survival of patients has improved thanks to advances in the
pharmacological field. In many guidelines, cardiotoxicity induced by anticancer drugs was defined …
pharmacological field. In many guidelines, cardiotoxicity induced by anticancer drugs was defined …
The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity
D Di Lisi, C Madaudo, G Alagna, M Santoro… - ESC Heart …, 2022 - Wiley Online Library
Aims Tyrosine kinase inhibitors (TKIs) used to treat chronic myeloid leukaemia (CML) can
cause cardiovascular adverse events. So far, the Systematic Coronary Risk Evaluation (…
cause cardiovascular adverse events. So far, the Systematic Coronary Risk Evaluation (…
Hereditary Transthyretin Amyloidosis: How to Differentiate Carriers and Patients Using Speckle-Tracking Echocardiography
D Di Lisi, F Brighina, G Manno, F Comparato… - Diagnostics, 2023 - mdpi.com
Background: Hereditary transthyretin amyloidosis is a rare disease caused by transthyretin (TTR)
gene mutations. The aim of our study was to identify early signs of cardiac involvement …
gene mutations. The aim of our study was to identify early signs of cardiac involvement …